Section 25607.45 - Delta-9-THC from Dermally Applied Products Exposure Warnings-Content(a) A warning for exposure to delta-9-tetrahydrocannabinol (delta-9-THC) from a cannabis or other consumer product that is intended for dermal application meets the requirements of this subarticle if it is provided using one or more of the methods required in Section 25607.44 and includes all the following elements: (1) The symbol required in Section 25603(a)(1);(2) The word "WARNING:" in all capital letters and bold print; and(3) The words: (A) "Using this product during pregnancy exposes your child to delta-9-THC, which can affect your child's behavior and learning ability. For more information go to www.P65Warnings.ca.gov/cannabis." or,(B) if the product will also expose consumers to one or more listed carcinogens, "Using this product exposes you to carcinogens including [name one or more listed carcinogens] and during pregnancy exposes your child to delta-9-THC, which can affect your child's behavior and learning ability. For more information go to www.P65Warnings.ca.gov/cannabis." Where the product only exposes the consumer to one listed carcinogen, consistent with Section 25603(a)(2)(E), the business may use the phrase "the carcinogen" rather than "carcinogens including" in the warning.Cal. Code Regs. Tit. 27, § 25607.45
1. New section filed 8-4-2022; operative 10-1-2022 (Register 2022, No. 31). Transmission deadline specified in Government Code section 11346.4(b) extended 60 calendar days pursuant to Executive Order N-40-20 and an additional 60 calendar days pursuant to Executive Order N-71-20. Note: Authority cited: Section 25249.12, Health and Safety Code. Reference: Sections 25249.6 and 25249.11, Health and Safety Code.
1. New section filed 8-4-2022; operative 10/1/2022 (Register 2022, No. 31). Transmission deadline specified in Government Code section 11346.4(b) extended 60 calendar days pursuant to Executive Order N-40-20 and an additional 60 calendar days pursuant to Executive Order N-71-20.